Drupal.behaviors.print = function(context) {window.print();window.close();}>
Waters Posts 8 Percent Jump in Q4 Revenues, Notes Growing Interest in Clinical Mass Spec
January 30, 2012
Waters Posts 8 Percent Jump in Q4 Revenues, Notes Growing Interest in Clinical Mass Spec
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Citing Disappointing Discovery Efforts, Researchers Look to Proteomics' Clinical Future
January 20, 2012 / ProteoMonitor
Waters Q3 Revenues Up 13 Percent as Synapt G2-S, Acquity I-Class Start Shipping
October 28, 2011 / ProteoMonitor
High-End Mass Spec Sales Drive Double-Digit Q4 Growth at Waters, AB Sciex
January 28, 2011 / ProteoMonitor
At JP Morgan, Vendors Tout Strong Mass Spec Releases as Antidotes to Academic/Government Gloom
January 13, 2012 / ProteoMonitor
Weakness in Proteomics and Life Science Research Contributes to Disappointing Q2 for Waters
July 29, 2011 / ProteoMonitor